CARBIDOPA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carbidopa, and when can generic versions of Carbidopa launch?
Carbidopa is a drug marketed by Alvogen, Ani Pharms, Aurobindo Pharma, Beximco Pharms Usa, Edenbridge Pharms, Novel Labs Inc, Zydus Pharms, Accord Hlthcare, Alembic, Apotex, Impax Labs, Kv Pharm, Mylan, Rubicon, Sciegen Pharms Inc, Sun Pharm Inds, Rising, Sun Pharm, Actavis Elizabeth, Apotex Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, SCS, Watson Labs, Norvium Bioscience, and Wockhardt Ltd. and is included in forty NDAs.
The generic ingredient in CARBIDOPA is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARBIDOPA?
- What are the global sales for CARBIDOPA?
- What is Average Wholesale Price for CARBIDOPA?
Summary for CARBIDOPA
| US Patents: | 0 |
| Applicants: | 26 |
| NDAs: | 40 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 210 |
| Patent Applications: | 4,753 |
| Drug Prices: | Drug price information for CARBIDOPA |
| What excipients (inactive ingredients) are in CARBIDOPA? | CARBIDOPA excipients list |
| DailyMed Link: | CARBIDOPA at DailyMed |
Recent Clinical Trials for CARBIDOPA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Affiliated Hospital of Qingdao University | Phase 1 |
| Impax Laboratories, LLC | Phase 1 |
| ISS, Inc. | Phase 2 |
Medical Subject Heading (MeSH) Categories for CARBIDOPA
US Patents and Regulatory Information for CARBIDOPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | CARBIDOPA, LEVODOPA AND ENTACAPONE | carbidopa; entacapone; levodopa | TABLET;ORAL | 203424-003 | Aug 13, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apotex Inc | CARBIDOPA AND LEVODOPA | carbidopa; levodopa | TABLET;ORAL | 077120-002 | Jun 2, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm | CARBIDOPA AND LEVODOPA | carbidopa; levodopa | TABLET, ORALLY DISINTEGRATING;ORAL | 078690-002 | Jul 31, 2009 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wockhardt Ltd | CARBIDOPA, LEVODOPA AND ENTACAPONE | carbidopa; entacapone; levodopa | TABLET;ORAL | 090833-002 | Nov 20, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
